The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Abiomed Inc | COM | 003654100 | 4,553 | 13,200 | SH | SOLE | 13,200 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 1,035 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| Adamas Pharmaceuticals Inc | COM | 00548A106 | 5,672 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
| Aerie Pharmaceuticals Inc | COM | 00771V108 | 5,908 | 125,179 | SH | SOLE | 125,179 | 0 | 0 | ||
| Agios Pharmaceuticals Inc | COM | 00847X104 | 2,159 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | ||
| Alexion Pharmaceuticals Inc | COM | 015351109 | 8,700 | 81,641 | SH | SOLE | 81,641 | 0 | 0 | ||
| Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 3,543 | 52,800 | SH | SOLE | 52,800 | 0 | 0 | ||
| Amicus Therapeutics Inc | COM | 03152W109 | 543 | 58,600 | SH | SOLE | 58,600 | 0 | 0 | ||
| Array Biopharma Inc | COM | 04269X105 | 9,844 | 844,500 | SH | SOLE | 844,500 | 0 | 0 | ||
| Biomarin Pharmaceutical Inc | COM | 09061G101 | 7,234 | 97,284 | SH | SOLE | 97,284 | 0 | 0 | ||
| Bluebird Bio Inc | COM | 09609G100 | 1,903 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
| Celgene Corp | COM | 151020104 | 17,398 | 253,522 | SH | SOLE | 253,522 | 0 | 0 | ||
| Corvus Pharmaceuticals Inc | COM | 221015100 | 710 | 108,000 | SH | SOLE | 108,000 | 0 | 0 | ||
| Cymabay Therapeutics Inc | COM | 23257D103 | 1,231 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| Deciphera Pharmaceuticals Inc | COM | 24344T101 | 2,286 | 77,000 | SH | SOLE | 77,000 | 0 | 0 | ||
| Exelixis Inc | COM | 30161Q104 | 9,574 | 704,534 | SH | SOLE | 704,534 | 0 | 0 | ||
| FibroGen Inc | COM | 31572Q808 | 1,464 | 31,400 | SH | SOLE | 31,400 | 0 | 0 | ||
| G1 Therapeutics Inc | COM | 3621LQ109 | 2,884 | 72,000 | SH | SOLE | 72,000 | 0 | 0 | ||
| Gilead Sciences Inc | COM | 375558103 | 5,346 | 90,284 | SH | SOLE | 90,284 | 0 | 0 | ||
| Globus Med Inc | COM | 379577208 | 1,262 | 29,000 | SH | SOLE | 29,000 | 0 | 0 | ||
| GW Pharmaceuticals Plc | ADS | 36197T103 | 1,272 | 9,600 | SH | SOLE | 9,600 | 0 | 0 | ||
| Halozyme Therapeutics Inc | COM | 40637H109 | 5,969 | 428,633 | SH | SOLE | 428,633 | 0 | 0 | ||
| Horizon Pharma Plc | SHS | G4617B105 | 1,036 | 69,000 | SH | SOLE | 69,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 14,522 | 51,600 | SH | SOLE | 51,600 | 0 | 0 | ||
| Incyte Corp | COM | 45337C102 | 10,593 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| Intersect Ent Inc | COM | 46071F103 | 2,469 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | ||
| Ionis Pharmaceuticals Inc | COM | 462222100 | 2,037 | 51,500 | SH | SOLE | 51,500 | 0 | 0 | ||
| Jazz Pharmaceuticals PLC | SHS USD | G50871105 | 2,785 | 21,600 | SH | SOLE | 21,600 | 0 | 0 | ||
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 5,467 | 322,436 | SH | SOLE | 322,436 | 0 | 0 | ||
| Ligand Pharmaceuticals Inc | COM | 53220K504 | 7,363 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| Madrigal Pharmaceuticals Inc | COM | 558868105 | 1,641 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| Merus N V | COM | N5749R100 | 1,136 | 75,060 | SH | SOLE | 75,060 | 0 | 0 | ||
| Neurocrine Biosciences Inc | COM | 64125C109 | 3,348 | 35,500 | SH | SOLE | 35,500 | 0 | 0 | ||
| Paratek Pharmaceuticals Inc | COM | 699374302 | 766 | 103,500 | SH | SOLE | 103,500 | 0 | 0 | ||
| Puma Biotechnology Inc | COM | 74587V107 | 5,074 | 144,300 | SH | SOLE | 144,300 | 0 | 0 | ||
| Radius Health Inc | COM | 750469207 | 257 | 18,799 | SH | SOLE | 18,799 | 0 | 0 | ||
| Regeneron Pharmaceuticals | COM | 75886F107 | 9,707 | 31,330 | SH | SOLE | 31,330 | 0 | 0 | ||
| ReShape Lifesciences Inc | COM | 761123108 | 2 | 52,546 | SH | SOLE | 52,546 | 0 | 0 | ||
| Sage Therapeutics Inc | COM | 78667J108 | 1,732 | 15,996 | SH | SOLE | 15,996 | 0 | 0 | ||
| Sangamo Therapeutics Inc | COM | 800677106 | 1,464 | 113,000 | SH | SOLE | 113,000 | 0 | 0 | ||
| Sarepta Therapeutics Inc | COM | 803607100 | 3,344 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
| Seattle Genetics Inc | COM | 812578102 | 2,513 | 42,500 | SH | SOLE | 42,500 | 0 | 0 | ||
| Shire plc | SPONSORED ADR | 82481R106 | 3,475 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| Spark Therapeutics Inc | COM | 84652J103 | 502 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | 3,863 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Spring Bk Pharmaceuticals Inc | COM | 849431101 | 673 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 7,459 | 585,930 | SH | SOLE | 585,930 | 0 | 0 | ||
| Supernus Pharmaceuticals Inc | COM | 868459108 | 809 | 20,953 | SH | SOLE | 20,953 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 1,686 | 146,653 | SH | SOLE | 146,653 | 0 | 0 | ||
| Vertex Pharmaceuticals Inc | COM | 92532F100 | 10,009 | 67,722 | SH | SOLE | 67,722 | 0 | 0 | ||
| Zogenix Inc | COM | 98978L204 | 4,184 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||